• Global health and access - how can comms better communicate pharma industry’s efforts in driving Universal Health Coverage? Striking a balance between industry and patients to improve medicine access.
• Reducing the pharmaceutical industry's carbon footprint - as environmental sustainability is increasingly a public health debate, what role can pharma industry play in embedding environmental sustainability?
• Preparing for the next pandemic - how should the industry communicate about its role in getting ready for the next pandemic?

Moderater:

John Harrington, Editor, PRWeek UK

• Working collaboratively together – the role of the NHS, healthcare organisations and pharmaceutical companies in ensuring equitable access to innovative medicines and clinical research 
• An update on the Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG) – the impact on clinical trials, manufacturing, collaboration, and innovation in the sector 
• Implementing a comprehensive patient engagement strategy – case studies of successful collaboration between industry and patient organisations

•The importance of brands doing more for social good than just the provision of healthcare

•The challenge of delivering, measuring and communicating social value

•Health inequality as priority area of focus for health brands and the unmet need in women’s health

• Examining the role of patient engagement platforms to enhance communications  and foster a sense of partnership in care. Supporting the healthcare journey - assisting patients by providing them with new ways to access information
  
• How to stop fake news in the pharmaceutical industry – from websites to social platforms, effective ways in which communicators can help combat the spread of misinformation. Designing a solid social media strategy and working hand-in-hand with compliance teams
• The rise of healthcare influencers and the impact of the pandemic on how audiences seek health news. What role do social media channels play in the overall patient landscape? Top tips to leveraging non-influencer credible voices in healthcare – using patient stories and creative editing to restore the balance of expert vs public opinion

Moderater:

John Harrington, Editor, PRWeek UK

• COVID-19 – from pandemic to endemic – repositioning corporate communications for the future
  
• Working together with internal and external stakeholders to address vaccine hesitancy and communicate vaccination benefits to patients
• Building trust in COVID-19 vaccine safety and science – defining corporate narratives to support vaccine confidence

Moderater:

John Harrington, Editor, PRWeek UK

• Navigating in a matrix organisation – how do you build and integrate a successful corporate affairs team? Lessons learned from a recent transformation project to merge public affairs, patient engagement and communication teams 
• Top tips to creating a high-performing culture that focuses on employee growth and development, as well as encourage creativity and innovation 
• Developing an effective governance model that optimises decision-making. Defining how roles interact and providing leadership during times of uncertainty and organisational transformation 
• On the road to measuring your team’s productivity – what are the most effective performance metrics to measure both short and long term goals

• Measuring pharmaceutical’s industry reputation – an update on the latest ABPI UK Pharma Reputation Index. What is the general public’s view of the pharmaceutical sector and in what areas can the sector improve?
  
• Improving the patient journey – beyond the pharma perspective. Developing compelling narratives to demonstrate the value that the pharmaceutical and healthcare industries add to the health system and research community
• Enabling communications innovation in a highly regulated industry – overcoming risk aversion and boosting creativity
• Raising credibility with the public and building trust-based relationships – top tips to developing and maintaining positive reputations with key stakeholder groups

Moderater:

John Harrington, Editor, PRWeek UK

• Discovering new exciting possibilities for pharma companies to work collaboratively together with charities, professional bodies, social care professionals  and patient organisations  to change the trajectory of heart failure
• Influencing transformative change - introducing a new innovative collaboration model to engage with the pharmaceutical industry 
• An update on the current status of 25in25 Collaborative – how pharma communicators can get involved in building a more equitable, inclusive, prosperous and sustainable future for patients

Moderater:

John Harrington, Editor, PRWeek UK

• Introducing an improvement in communication between the public world and the pharmaceutical industry. Sharing powerful stories to create emotions, build empathy and increase disease awareness 
• Winning the trust of generation Z – successful communication strategies that resonate with this influential generation 
• Effectively differentiating social media content across various platforms – focus on LinkedIn, Instagram and TikTok 
• Building trust in the pharmaceutical industry – how to successfully educate and engage with patients. Real-life examples of innovative awareness campaigns in oncology and cardiology

• The role of leaders in developing tangible diversity, equity and inclusion objectives and embedding inclusion into work practices, behaviours and values

• Best practice: Demonstrating the true value of diversity, equality and inclusion in pharma

• Two DEI case studies: communicating clinical trial diversity efforts and communication STEM equity investment

• Debating the potential of AI in pharma communications – from identifying information to writing summaries and patient insight briefs. Discussing AI’s limitations. Is AI a risk to creativity? 
• Discovering the benefits of AI in improving work efficiencies and addressing organisational challenges. Could AI put the communications professional out of a job? 
• Ensuring responsible use of generative AI. What policies and regulatory frameworks are there in place to allow innovation whilst protecting organisations and individuals? 
• Best practice examples of how AI is being used by pharma communicators. What works and what doesn’t?

Moderater:

Siobhan Holt, News Editor, PRWeek UK